Cardinal Health, Inc. (NYSE:CAH – Get Rating) shares have earned an average rating of “Hold” from the thirteen brokerages that currently cover the company, MarketBeat reports. Six research analysts rated the stock with a hold recommendation, two gave the company a buy recommendation and one gave the company a strong buy recommendation. The 12-month average price target among analysts who have rated the stock over the past year is $74.36.
A number of research companies have published reports on HCS. Mizuho raised its price target on Cardinal Health from $58.00 to $66.00 in a Friday, August 12 research note. Robert W. Baird raised his price target on Cardinal Health from $74.00 to $82.00 and gave the company a “neutral” rating in a Monday, Nov. 7 research note. StockNews.com upgraded Cardinal Health from a “buy” rating to a “strong buy” rating in a research rating on Friday. Cowen raised his price target on Cardinal Health from $59.00 to $72.00 and gave the company a “market performance” rating in a Tuesday, August 16 research note. Finally, Credit Suisse Group raised its price target on Cardinal Health from $56.00 to $64.00 and gave the company a “neutral” rating in a Friday, August 12 research note.
Performance of Cardinal Health shares
NYSE CAH opened at $75.27 on Monday. Cardinal Health has a one-year low of $45.85 and a one-year high of $81.57. The stock has a 50-day moving average of $71.07 and a 200-day moving average of $62.72. The company has a market capitalization of $19.73 billion, a price-earnings ratio of 12.30, a PEG ratio of 1.32 and a beta of 0.80.
Cardinal Health (NYSE:CAH – Get Rating) last released its quarterly earnings data on Thursday, August 11. The company reported EPS of $1.05 for the quarter, missing the consensus estimate of $1.17 per ($0.12). Cardinal Health had a negative return on equity of 252.82% and a negative net margin of 0.59%. The company posted revenue of $47.10 billion in the quarter, versus a consensus estimate of $44.82 billion. In the same quarter a year earlier, the company posted earnings per share of $0.77. Cardinal Health’s quarterly revenue increased 10.6% compared to the same quarter last year. On average, stock analysts predict Cardinal Health will post earnings per share of 5.26 for the current fiscal year.
Cardinal Health Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Sunday, January 15. Investors of record on Tuesday, January 3 will receive a dividend of $0.4957. The ex-date of this dividend is Friday, December 30. This represents a dividend of $1.98 on an annualized basis and a yield of 2.63%. Cardinal Health’s dividend payout ratio is currently 32.35%.
Insider buying and selling
In other news, insider Ola M. Snow sold 19,590 shares of the company in a trade that took place on Monday, November 7. The stock was sold at an average price of $78.87, for a total transaction of $1,545,063.30. Following the sale, the insider now directly owns 31,187 shares of the company, valued at approximately $2,459,718.69. The sale was disclosed in a legal filing with the Securities & Exchange Commission, accessible via this hyperlink. 0.17% of the shares are held by insiders.
Cardinal Health Institutional Trading
Hedge funds have recently changed their holdings in the company. BOK Financial Private Wealth Inc. bought a new position in Cardinal Health stock during Q3, valued at around $28,000. Manchester Capital Management LLC increased its position in Cardinal Health by 60.4% in Q1. Manchester Capital Management LLC now owns 494 shares of the company valued at $28,000 after acquiring 186 additional shares in the last quarter. LS Investment Advisors LLC bought a new position in Cardinal Health in Q2 worth $27,000. Capital Advisors Ltd. LLC increased its position in Cardinal Health by 29.5% in Q3. Capital Advisors Ltd. LLC now owns 589 shares of the company valued at $39,000 after acquiring 134 additional shares in the last quarter. Finally, CX Institutional bought a new position in Cardinal Health in Q2 worth $33,000. 85.07% of the shares are held by hedge funds and other institutional investors.
About Cardinal Health
(Get a rating)
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia and internationally. It provides customized solutions for hospitals, health systems, pharmacies, ambulatory surgery centers, clinical laboratories, medical offices and home patients.
This instant news alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to cont[email protected]
Before you consider Cardinal Health, you’ll want to hear this.
MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes off…and Cardinal Health wasn’t on the list.
Although Cardinal Health currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
See the five actions here